Clinical Trials Sponsored by Targeted Medical Pharma

Total 387 results

Targeted Medical Pharma

Unknown

A Clinical Outcomes Study to Measure Reduction in Pain and Numbness During Administration of an Amino Acid Formulation in Subjects Diagnosed With Peripheral Neuropathy (Neuron012703)

Diabetic Neuropathy | Chemotherapy Induced Neuropathy | HIV Neuropathy | Trauma Induced Neuropathy

United States
Targeted Medical Pharma

Terminated

A Randomized Double-Blind Placebo Controlled Trial to Determine the Status of Post Knee Chondroplasty Patients Administered Theramine Versus Placebo in Addition to Post Surgery Analgesics

Knee Pain | Knee Chondroplasty

United States
Targeted Medical Pharma

Withdrawn

Red Blood Cell Precursor Formulation to Determine Increased Production (RBCPF)

Anemia

United States
Targeted Medical Pharma

Unknown

An Open-label Trial to Determine Increased Red Blood Cell Production in Subjects With Anemia of Chronic Disease

Anemia of Chronic Disease

United States
Targeted Medical Pharma

Completed

Effectiveness of Theramine on Chronic Back Pain

Low Back Pain
Targeted Medical Pharma

Completed

A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain

Chronic Low Back Pain

United States
Targeted Medical Pharma

Completed

A Double-blind Placebo Controlled Trial of Sentra PM, a Medical Food

Sleep Disorder

United States
Stephanie Pavlik

Completed

Sentra AM® and Sentra PM® for Post-traumatic Stress Disorder (PTSD) and Gulf War Fibromyalgia (GWF) (GWF001)

Persian Gulf Syndrome | Post-traumatic Stress Disorder

United States
Vincent Martin, MD
Targeted Medical Pharma

Terminated

Theramine® in the Prevention of Migraine Headache

Migraine Headaches

United States
Targeted Medical Education

Unknown

TME Neoadjuvant Breast Registry

Breast Cancer | Breast Neoplasms

United States
Juva Life
Targeted Medical Education

Recruiting

The JULI Registry--Hemp and Cannabis Observational Registry (JULI)

Chronic Pain | Nausea | Anxiety | Sleep Disturbance | Neuropathy | Appetite Disorders | Menopausal Syndrome

United States
NewAmsterdam Pharma
Pharma Medica Research, Inc.

Completed

A Drug-drug Interaction Study Evaluating the PK Effects of Obicetrapib on Atorvastatin and Rosuvastatin

Healthy Volunteers

Canada
Shenzhen TargetRx, Inc.
First Affiliated Hospital Bengbu Medical College

Completed

TGRX-326 Phase I/II Pharmacokinetic Study

Non Small Cell Lung Cancer

China
Nasus Pharma
Hadassah Medical Organization; Pharma Medica Research, Inc.; Medistat Ltd., Israel

Completed

Comparative Bioavailability of Intranasal Epinephrine

Anaphylaxis | Anaphylactic Reaction

Israel
Rabin Medical Center
Astellas Pharma Inc; Teva Pharma

Unknown

Incidence of Non Adherence to Treatment With Once-daily Formulation of Tacrolimus (Advagraf)

Medication Adherence

Israel
Seung-Jung Park
Roche Pharma AG; AstraZeneca; KBM pharm

Completed

Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes (OPTIMA)

Acute Coronary Syndrome

Korea, Republic of
Medical Center Haaglanden
UCB Pharma

Unknown

Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus

Status Epilepticus

Netherlands
gicare Pharma Inc.
Algorithme Pharma Inc; JSS Medical Research Inc.

Completed

A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy

Pain | Cancer | Colonic Diseases

United States, Canada
Vifor Fresenius Medical Care Renal Pharma

Recruiting

Avacostar - (PASS) (Avacostar)

ANCA-associated Vasculitis

United Kingdom, Germany
Vifor Fresenius Medical Care Renal Pharma

Completed

Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD) (VERIFIE)

Hyperphosphatemia

Spain, Netherlands, Germany, Italy, France, Greece, United Kingdom
Samsung Medical Center
Yuyu Pharma, Inc.

Unknown

Clopidogrel Resistance and Embolism in Carotid Artery Stenting (CRECAS)

Carotid Stenosis

Korea, Republic of
Vanderbilt University Medical Center
UCB Pharma

Completed

Study to Look at Benefit of Surgical Drainage Before Beginning Medical Therapy for Crohns Perianal Fistulas

Fistula | Abscess | Crohns Disease

United States
Asan Medical Center
Astellas Pharma Inc

Unknown

Impact of Tamsulosin on Voiding Patterns Following Early Catheter Removal After Robot-assisted Laparoscopic Radical Prostatectomy

Prostatic Neoplasms, Prostatectomy

Korea, Republic of
Swedish Medical Center
Roche Pharma AG

Completed

Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer

Pancreatic Cancer

United States
Dafra Pharma
Kenya Medical Research Institute

Completed

Randomised Efficacy Study of Two Artemether-Lumefantrine Oral Formulations for the Treatment of Uncomplicated P. Falciparum Malaria

Malaria, Falciparum

Kenya
Swedish Medical Center
Acerta Pharma BV

Recruiting

Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL

Diffuse Large B Cell Lymphoma

United States
Maastricht University Medical Center
Vifor Pharma

Terminated

The Use of Iron Therapy for Patients With Anemia After Caesarean Section (VITAPOP)

Postoperative Anaemia

Netherlands
Asan Medical Center
Roche Pharma AG

Completed

Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer

Advanced Gastric Cancer

Korea, Republic of
University Medical Center Groningen
Teva Pharma

Completed

Effects of QVAR in Smokers With Asthma (OLiVIA)

Asthma

Netherlands
Hannover Medical School
Roche Pharma AG

Unknown

Prospective Intervention Study to Improve HRQoL and Exercise Tolerance After Lung Transplantation (Ergo-LTx) (Ergo-LTx)

Lung Transplantation
Hannover Medical School
Roche Pharma AG

Unknown

Prospective Intervention Study to Improve HRQoL and Exercise Tolerance After Heart Transplantation (Ergo-HTx)

Heart Transplantation | Exercise Capacity
Solasia Pharma K.K.
Proswell Medical Corporation

Completed

A Randomized Controlled Trial of SP-01 (Granisetron Transdermal Delivery System) in Chemotherapy-induced Nausea and Vomiting

Chemotherapy-induced Nausea and Vomiting

China
Vifor Fresenius Medical Care Renal Pharma

Completed

PA21 Safety and Efficacy in Adult Chinese Subjects

Hyperphosphatemia | Chronic Kidney Disease Requiring Chronic Dialysis

China
Vifor Fresenius Medical Care Renal Pharma

Terminated

A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia

Hyperphosphatemia

United States, Poland, Germany, Lithuania, France, Romania, Russian Federation
Oklahoma Medical Research Foundation
UCB Pharma

Completed

The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients (PICS)

Rheumatoid Arthritis

United States
Asan Medical Center
Astellas Pharma Inc

Unknown

Study on Bladder and Sexual Function Change After Simple Hysterectomy

Benign Uterine Disease

Korea, Republic of
Vanderbilt University Medical Center
UCB Pharma

Completed

Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease Activity

Crohn's Disease

United States
Samsung Medical Center
Roche Pharma AG

Terminated

Xeloda Maintenance Versus BSC in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Korea, Republic of
Kenya Medical Research Institute
Dafra Pharma

Completed

A Randomised Trial of Artesunate-sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel for the Treatment of S. Mansoni

Schistosoma Mansoni

Kenya
Medicago
Mitsubishi Tanabe Pharma Corporation

Terminated

Safety Immunogenicity Study of MT-2766 in Japanese Adults（COVID-19）

SARS-CoV-2 Infection

Japan
MBQ Pharma
Congressionally Directed Medical Research Programs

Recruiting

A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer

Breast Cancer | Breast Neoplasm | Breast Cancer Stage IV

Puerto Rico
Soroka University Medical Center
Roche Pharma AG

Completed

Treatment With Pirfenidone for COVID-19 Related Severe ARDS

Covid19 | ARDS

Israel
Maastricht University Medical Center
Roche Pharma AG

Completed

Ribavirin, Its Dosing Regime (Ribados)

Hepatitis C

Netherlands
Vifor Pharma
Fresenius Medical Care North America

Completed

A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients

Chronic Kidney Disease Requiring Chronic Dialysis

Latvia, United States, Belgium, Croatia, Austria, Czech Republic, Germany, Lithuania, Poland, Romania, Russian Federation, Serbia, South Africa, Ukraine, United Kingdom
Asan Medical Center
Astellas Pharma Korea, Inc.

Unknown

Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation

Neutropenia | Hematopoietic Stem Cell Transplantation | Invasive Fungal Disease

Korea, Republic of
Medical University Innsbruck
Orion Corporation, Orion Pharma

Unknown

Efficacy and Safety of Pulsed Infusions of Levosimendan in Outpatients With Advanced Heart Failure (LevoRep)

Chronic Stable Heart Failure

Austria, Greece
Medical University of Vienna
Vifor Pharma, Inc.

Recruiting

Iron Status in Female Infertility and Recurrent Miscarriage

Infertility | Iron-deficiency | Recurrent Miscarriage

Austria
Medical University of Warsaw
Adamed Pharma S.A.

Not yet recruiting

L Rhamnosus ATCC 53103 & L Reuteri DSM 29063 Compared With L Rhamnosus ATCC 53103 for Preventing AAD in Children (FLOSTRUM)

Antibiotic-associated Diarrhea

Poland
Sheba Medical Center
Naveh Pharma (1996) Ltd.

Recruiting

The Impact of Magnesium on Exercise Tolerance, Quality of Life and Clinical Outcomes in Chronic Heart Failure Patients

Heart Failure | Magnesium Deficiency

Israel
PepTonic Medical AB
Pharma Consulting Group AB

Completed

Dose-relationship of Vaginally Administrated Oxytocin in Postmenopausal Women (OXYPEP002)

Vaginal Atrophy

Sweden

Clinical Trials Sponsored by Targeted Medical Pharma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations